MedDataX Logo

Why Still in Neurosurgical Ward After Tumor Craniotomy?

NCT ID: NCT05288088

Last Updated: 2023-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-12

Study Completion Date

2023-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this prospective observational study is to identify the specific reasons that prolong a hospital stay after elective tumor craniotomy. Optimal postoperative in-hospital stay is considered to be two days from surgery to discharge from the neurosurgical ward. However, a variable length of stay at a neurological department for follow-up of late recognized deficits of neurological consequences of the surgical procedure are common.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Post-craniotomy Headache in Siriraj Hospital

NCT01806155

Adult Brain Tumor Headache
UNKNOWN

Risk Factors of Complications Regarding Patients Undergoing Brain Tumour Neuro-surgery (Cranioscore).

NCT01801813

Neuro-surgery Brain Tumor Post-operative Complications +1 more
COMPLETED

Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients

NCT02530749

Brain Tumors
COMPLETED

Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma

NCT06885333

Glioma Glioma : Oligodendroglioma or Astrocytoma
COMPLETED

Postoperative Complications Following Skull Base Tumor Resection

NCT06587906

Skull Base Tumor Postoperative Complications
RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The concept of fast-track surgery and later enhanced recovery after surgery (ERAS) was first imputed in 1990s. Since then, ERAS protocols have been successfully adopted in many surgical fields, often with dramatic benefits for the patients. Length of hospital stay is one of the main questions addressed in many ERAS studies, as it by a simple approach address many of the complications encountered by the patients or the case flow in the perioperative period. Why patients have prolonged hospital stay after surgery has been investigated by Husted et al. in 2011 after hip and knee arthroplasty and P. Munk-Madsen et al. in 2019 after laparoscopic colorectal surgery. Both studies could isolate dominating factors prolonging hospital stay, some of them preventable. Existing length of stay studies on tumor craniotomy patients have focused on specific variables affecting hospital duration, but never explored the true cause of prolonged hospitalization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery--Complications Brain Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tumor craniotomy patients

Patients undergoing elective brain tumor craniotomy

No intervention

Intervention Type DIAGNOSTIC_TEST

This is an observational study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

This is an observational study

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients scheduled for elective brain tumor craniotomy

Exclusion Criteria

* Stereotactic biopsy, pituitary surgery and laser interstitial thermal therapy (LITT)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alexandra Vassilieva

Medical doctor, PhD-student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martin K Sørensen, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Neuroanesthesiology, Rigshospitalet

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Neuroanesthesiology, Rigshospitalet

Copenhagen, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NSwardcraniotomy

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Factors in Human Brain Tumors
NCT00001171 COMPLETED
Surgical Resection of Latent Brain Tumors Prior to Recurrence
NCT04810871 SUSPENDED NA
Long Term Survivors of High-grade Glioma and Their Caregivers
NCT02965144 COMPLETED
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
NCT01417507 COMPLETED
Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal
NCT02790294 COMPLETED NA
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
NCT03861299 RECRUITING NA
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
NCT02851706 COMPLETED
Supratotal Resection for Gliomas Within Noneloquent Areas
NCT02676687 UNKNOWN NA
Magnesium and Intraoperative Blood Loss in Meningioma Surgery
NCT03558516 COMPLETED PHASE3
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
NCT01668082 RECRUITING NA
Awake vs. Asleep Craniotomy for Non-eloquent Gliomas
NCT03621748 COMPLETED NA
Ketogenic Diet for Recurrent Glioblastoma
NCT00575146 COMPLETED PHASE1
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
NCT04822688 COMPLETED
Neurosurgical Outcome Network
NCT06724029 RECRUITING
Risk Factors for Adult-Onset Brain Tumors
NCT00592865 TERMINATED
General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas
NCT05485038 SUSPENDED NA
Anterior Temporal Lobectomy in Temporal Glioblastoma
NCT07021339 RECRUITING PHASE3
Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
NCT04553757 ACTIVE_NOT_RECRUITING
PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
NCT02854228 UNKNOWN
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
NCT05564949 RECRUITING NA
Treatment Decision-making in Patients With Recurrent High-grade Glioma
NCT04013828 COMPLETED
Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI
NCT02884947 COMPLETED
Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over
NCT02892708 COMPLETED PHASE3
Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
NCT07342699 COMPLETED
Pituitary Tumor Surveillance: Pathogenic Correlation
NCT00599092 RECRUITING